Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20211216053428N1Phase 3Completed
Phase 3 trial of mometasone in atopic dermatitis (AD) (2 arms), sponsored by Vice Chancellor for Research of Isfahan University of Medical Sciences. Started Jan 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20211216053428N1.